icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
Antiviral activity of JNJ-4964 (AL-034/TQ-A3334),a selective Toll-Like Receptor 7 agonist, after oral administration for 12 weeks in AAV/HBV mice
 
 
  Reported by Jules Levin
EASL 2019 April 10-14 Vienna
 
Florence Herschke1, Chris Li2, Ren Zhu2, Qinglin Han2, Qing Lu2, Erio Barale1, Sandra De Jonghe1, Tse-I Lin3,An De Creus1
 
1Janssen PharmaceuticaNV, Beerse, Belgium
2Janssen China R&D Center, Shanghai, China
3Formerly Janssen Biopharma (a Janssen Pharmaceuticals company), San Francisco, USA

0418191

0418192

0418193

0418194

0418195

0418196

0418197

0418198

0418199

04181910

04181911